Enzo life sciences intl DBA enzo diagnostics - pharmacologic mitigation of radiation-induced CNS toxicity.

Ended Purchase Order Awarded Last action

Contract number
75N91018P00453
Awardee
Awarding agency
Obligated
$28,140

Award facts

Opportunity
Contract value 100% obligated
$28,140.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Farmingdale, NY 11735, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Enzo Life Sciences, Inc. for $28,140.30 on July 16, 2018, for pharmacologic mitigation of radiation-induced CNS toxicity. The awardee is a small disadvantaged business. Work is performed in Farmingdale, New York. The order carries firm fixed price terms and completion is due August 31, 2018.

Quick answers

Who was awarded contract 75N91018P00453?

75N91018P00453 was awarded to Enzo Life Sciences, Inc. by National Cancer Institute (National Institutes of Health) on July 16, 2018.

How much is contract 75N91018P00453 worth?

The government has obligated $28,140 on 75N91018P00453.

Was contract 75N91018P00453 competed?

The extent of competition for 75N91018P00453 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login